Tekla Capital Management LLC trimmed its position in shares of Merus (NASDAQ:MRUS – Get Rating) by 45.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 92,325 shares of the biotechnology company’s stock after selling 76,882 shares during the period. Tekla Capital […]